Clinical Trial Update: The Molecular Characterization of Multiple Myeloma at Relapse

View source ↗

Summary

The trial update reports completed efforts to characterize the molecular features of multiple myeloma at relapse, focusing on biomarker and genetic profiling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Multiple Myeloma | Status: COMPLETED